ADHEREX ANNOUNCES RESULTS OF ANNUAL AND SPECIAL MEETING Read more about ADHEREX ANNOUNCES RESULTS OF ANNUAL AND SPECIAL MEETING
ADHEREX ANNOUNCES RESULTS FROM TWO SODIUM THIOSULFATE PHASE 3 STUDIES PRESENTED AT THE 50TH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING Read more about ADHEREX ANNOUNCES RESULTS FROM TWO SODIUM THIOSULFATE PHASE 3 STUDIES PRESENTED AT THE 50TH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING
ADHEREX TECHNOLOGIES INC. ANNOUNCES WARRANT EXCHANGE Read more about ADHEREX TECHNOLOGIES INC. ANNOUNCES WARRANT EXCHANGE
ADHEREX ANNOUNCES WARRANT EXCHANGE RESULTS AND NEW CAPITAL STRUCTURE Read more about ADHEREX ANNOUNCES WARRANT EXCHANGE RESULTS AND NEW CAPITAL STRUCTURE
ADHEREX PROVIDES CORPORATE UPDATE AND SECOND QUARTER ENDED JUNE 30, 2014 FINANCIAL RESULTS Read more about ADHEREX PROVIDES CORPORATE UPDATE AND SECOND QUARTER ENDED JUNE 30, 2014 FINANCIAL RESULTS
ADHEREX ANNOUNCES SHARE CONSOLIDATION, NAME CHANGE AND TRADING SYMBOL CHANGE Read more about ADHEREX ANNOUNCES SHARE CONSOLIDATION, NAME CHANGE AND TRADING SYMBOL CHANGE
FENNEC PHARMACEUTICALS ANNOUNCES OVER THE COUNTER TRADING SYMBOL CHANGE Read more about FENNEC PHARMACEUTICALS ANNOUNCES OVER THE COUNTER TRADING SYMBOL CHANGE
FENNEC PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND THIRD QUARTER ENDED SEPTEMBER 30, 2014 FINANCIAL RESULTS Read more about FENNEC PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND THIRD QUARTER ENDED SEPTEMBER 30, 2014 FINANCIAL RESULTS
FENNEC ANNOUNCES PRIVATE PLACEMENT OF UNITS Read more about FENNEC ANNOUNCES PRIVATE PLACEMENT OF UNITS
